Chennai-based Trivitron, one of the largest indigenous manufacturers of medical devices, is setting up an Rs 250-crore medical technology park near Chennai in collaboration with a number of foreign partners with a view to make products of international standards as per Indian needs.

The state-of-the-art facility, the first of its kind in the country, will come up at 25 acre land and the plants will go for CE and US FDA accreditations to churn out quality products. The first phase of the park, at Rs 250 crore would be operational by 2009, its managing director Dr G S K Velu told Pharmabiz.

``We have applied for the land and we are still to finalise on taking the route of SEZ or medical technology park, which is possible only if the government comes out with some special scheme to promote the domestic medical devices manufacturers,'' he said.

Aloka of Japan, Biosystems from Spain and number of other companies have either finalised joint ventures or in the process of the same with Trivitron to set up units in the park. The units in the park will be either joint ventures or own units by Trivitron.

The second phase of the park will be developed in three years from 2009. The facility will consists of an electronics and electro-mechanical manufacturing unit for production of various products like ultrasound scanners and colour dopplers , operation theatre lights, operation tables, ventilators and other breathing apparatus, infusion and syringe pumps, clinical laboratory equipments and neonatology equipments. It will have a diagnostics reagents manufacturing unit for full-fledge production of haematology reagents, clinical chemistry reagents, besides a unit for medical consumables like catheters, anaesthesia consumables etc.

Dr Velu said his company has already acquired two small devices manufacturers and is in talks with three others to produce low-end products. The high-end products from the group would be manufactured in the medical park.

The company is expecting an Rs 200 crore revenue for the current fiscal year and 95 per cent of the turnover would come from trading imported products. But it has set a target of Rs 1000 crore by 2010-11 and 50 per cent of the turnover would be generated through selling its own products manufactured in the country.

Trivitron specialises in a comprehensive range of medical device solutions covering the fields of imaging, cardiology, nephrology, critical care, orthopaedics, anaesthesiology, intensive care, obstetrics & gynaecology, radiology, urology, ophthalmology, gastroenterology, microbiology, biochemistry, haematology, immunology, molecular biology, blood banking, surgery, home care & geriatrics.